Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05984680 · ClinicalTrials.gov registry record
COPD Care Pathway Among Patients With Cancer
A clinical trial of Lung Cancer and Head and Neck Cancer, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- 101
- Enrollment target
- 1
- Study location
NCT05984680 is a study of Lung Cancer and Head and Neck Cancer that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 101 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05984680, a study of Lung Cancer and Head and Neck Cancer, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- 101 participants
- Enrollment target
- 1
- Study location
Study Summary
This study gathers information for the development of a COPD care pathway for patients with cancer that reduces the treatment burden of patients, implements critical components of COPD care, and overcomes common barriers to COPD care in the community oncology clinic.
Conditions Studied
Interventions
- OTHER Observational Phase 1
- OTHER Observational Phase 2, Group I
- OTHER Observational Phase 2, Group II
- OTHER Observational Phase 3
Study Locations (1)
North Carolina
- Wake Forest Baptist Comprehensive Cancer Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2025-02-27 |
| Est. Completion | 2026-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05984680
The ClinicalTrials.gov registry entry for NCT05984680 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (89% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Lung Cancer appearing as the primary indexed condition, and to 4 interventions - of which Observational Phase 1 is the first listed.
NCT05984680 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT05984680 about?
NCT05984680 is a clinical study titled "COPD Care Pathway Among Patients With Cancer". This study gathers information for the development of a COPD care pathway for patients with cancer that reduces the treatment burden of patients, implements critical components of COPD care, and overcomes common barriers to COPD care in the community oncology clinic.
What is the current status of trial NCT05984680?
This trial is currently recruiting. The enrollment target is 101 participants. The study started on 2025-02-27. Estimated completion is 2026-05.
What conditions does trial NCT05984680 study?
This clinical trial studies the following conditions: Lung Cancer, Head and Neck Cancer, Chronic Obstructive Pulmonary Disease.
What interventions are being tested in trial NCT05984680?
The interventions under investigation include: Observational Phase 1 (OTHER), Observational Phase 2, Group I (OTHER), Observational Phase 2, Group II (OTHER), Observational Phase 3 (OTHER).
Who is sponsoring clinical trial NCT05984680?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05984680 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.